Policy and Legislation
Rebates and fees received by PBMs account for 42% of every dollar spent on brand medicines in the commercial market, report says.
Improperly listing patents may harm competition from generic alternatives and keep prices artificially high, the FTC says.
Erik Decker, vice president and CISO at Intermountain Health and chair of the Health Sector Council's Cybersecurity Working Group, discusses the group's collaboration with the U.S. government to support healthcare data security mandates.
Hospitals face a $15,000 fine for the first violation, with the state narrowing the circumstances for exceptions.
The vaccines from Pfizer-BioNTech and Moderna will be available later this week, CDC says.
The number of hospitalizations and deaths in the United States continues to rise.
Facilities and insurers would be compelled to list the prices they charge patients and PBMs to disclose rebates and discounts.
Healthcare is a growing sector of the economy including the export of pharmaceuticals, medical equipment and devices, says Filipe Santos Costa, chairman and CEO of AICEP.
With the expiration of the public health emergency ending waivers and flexibilities, providers are looking for answers, says Dr. Robert Murry, chief medical officer of NextGen Healthcare.
HIMSS23
Because health organizations are paid by capitation, incentives are aligned to keep the patient healthy, says Ran Balicer, chief innovation officer at Clalit Health Services.